The Scientist

» drug development, ecology and evolution

Most Recent

image: Ebola Evolved to Become More Infectious

Ebola Evolved to Become More Infectious

By | November 7, 2016

A mutation that appeared early in the 2014 outbreak made the virus more infectious in humans, scientists show.

0 Comments

image: New Support for Experimental Alzheimer’s Drug

New Support for Experimental Alzheimer’s Drug

By | November 2, 2016

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

2 Comments

image: Protein Folding Pioneer Dies

Protein Folding Pioneer Dies

By | October 28, 2016

Susan Lindquist of MIT and the Whitehead Institute broke scientific ground on prions and heat shock proteins.

0 Comments

image: Week in Review: October 17–21

Week in Review: October 17–21

By | October 21, 2016

Report finds that pathologist involved in anonymous defamation case committed multiple acts of misconduct; growing eggs from stem cells; neutrophils’ role in metastasis; convergent evolution in birds

0 Comments

image: Cuban-U.S. Research Collaborations Easier Now

Cuban-U.S. Research Collaborations Easier Now

By | October 18, 2016

President Obama’s executive actions remove some of the red tape for American and Cuban scientists to work together.

0 Comments

image: Single-Celled Life Primed to Go Multicellular

Single-Celled Life Primed to Go Multicellular

By | October 17, 2016

The unicellular ancestor of animals may have harbored some of the molecular tools that its many-celled descendants use to coordinate and direct cell differentiation and function, scientists show.

0 Comments

image: Deep-Sea Viruses Destroy Archaea

Deep-Sea Viruses Destroy Archaea

By | October 12, 2016

Viruses are responsible for the majority of archaea deaths on the deep ocean floors, scientists show.

4 Comments

image: Pet Meds Adapted from Human Therapies

Pet Meds Adapted from Human Therapies

By | October 1, 2016

Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market.

0 Comments

image: Q&A: From FDA to Industry

Q&A: From FDA to Industry

By | September 27, 2016

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

1 Comment

image: Allergan’s Buying Spree Rolls On

Allergan’s Buying Spree Rolls On

By | September 21, 2016

The Ireland-based pharma company makes a $1.7 billion offer to acquire Tobira Therapeutics, a US firm developing liver disease drugs.

0 Comments

Popular Now

  1. An Aging-Related Effect on the Circadian Clock
  2. Marching for Science, from Berlin to Sydney
  3. ADHD Linked to Structural Differences in the Brain
  4. Opinion: Is a Clone Really Born at Age Zero?
Business Birmingham